Hypospadias Panel
Use
This test is designed for individuals with features indicative of hypospadias or a clinical diagnosis suggesting a genetic basis for abnormal genital development. It is targeted towards males who exhibit atypical development of external genitalia and may require a genetic diagnosis. Additionally, it aids individuals with hypospadias accompanied by further genitourinary anomalies.
Special Instructions
Tests are developed and validated by Prevention Genetics LLC. Orders must be placed by a qualified healthcare provider, and require completion of an online order or paper test requisition form (TRF) with a labeled specimen to initiate testing.
Limitations
The results may not detect all genetic abnormalities and the clinical significance of some variants may not be fully understood. Test interpretations are contingent on the quality of the clinical information provided. The test has not been cleared or approved by the FDA.
New York Approved
Methodology
NGS
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided